Rapid communication · 29 May 2025
CommentaryPublished 22 Aug 2020
Diabetes and Covid-19 Pandemic-A T1 Patient Perspective
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
How might we successfully treat diabetes patients who become seriously ill and hospitalised sufffering from Coronavirus and requiring ventillator breathing assistance? Coronavirus, Covid-19 is the most feared pandemic ever experienced on a global scale with dramatic morbidity and is challenging to treat and overcome. Media reports suggest that 25% of patients who die from Coronavirus are elderly and have an underlying health condition, often diabetes. Could inhaled therapy drug treatment delivered to Critical Care Patients with the Multisonic®Infracontrol Nebuliser lead to improved recovery and reduced morbidity?
Subjects
Diabetes & EndocrinologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Diabetes & Metabolism.
Rapid communication · 29 May 2025
Genetic and epigenetic markers for gdm risk
Short communication · 29 May 2025
Metabolic syndrome: Diet, timed eating, supplements
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Diabetes & Metabolism
- SubjectDiabetes & Endocrinology
- BylineArticles whose byline prints “Derek C Beatty”